BioLife Europe currently operates more than 30 such centres in Europe, ten of which are in Austria, four of these ten located in Vienna. The plasma is needed for the production of medicines. "Many active ingredients cannot be synthetically manufactured. For this reason, plasma donations are so important, because they provide the basic material for numerous vital drugs which we produce at Takeda and supply to the entire world from Vienna", explained Kirsten Detrick, General Manager Takeda Austria.
Austria is a trailblazer in the field of plasma donations. Europe's very first plasma donation centre was opened in Vienna in 1964. Moreover, Vienna continues to be a global plasma hub. About five million of the total worldwide volume of 60 million litres of donated plasma are processed into medicinal products in fractionation plants in Vienna. The field of medicine requires an increasing amount of plasma protein preparations due to their effectiveness and growing demand. The need for immunoglobulin has risen from 47.4 tonnes in the year 2000 to 197 tonnes in 2018. According to forecasts, some 335 tonnes will be required in 2026.
Read about the life sciences sector in Austria.